February 26, 2001
Drugs Under Development in Japanese Companies Keiji Nakamura, Ph. D., Pharma Forum Institute Because the stagnant Japanese pharmaceutical market is predicting a looming crisis in health insurance, Japanese companies should look to markets abroad, especially the USA, which plays a...read more